Skip to main content

Table 3 Comparison of lung function, impulse oscillometry, and radiographic measurements of subjects by fixed ratio-defined lung function categories

From: Preserved ratio impaired spirometry is associated with small airway dysfunction and reduced total lung capacity

Parameter

Healthy control

(n = 628)

PRISm

(n = 126)

Spirometry-defined COPD (n = 685)

Lung Function

   

Before bronchodilator use

   

MMEF, L/s

2.01 ± 0.84

1.29 ± 0.54*†

0.78 ± 0.40

MMEF% of predicted, %

80.6 ± 29.4

54.1 ± 19.0*†

31.9 ± 15.1

FEF50, L/s

2.76 ± 1.04

1.84 ± 0.74*†

1.07 ± 0.60

FEF50% of predicted, %

83.7 ± 27.6

57.8 ± 19.5*†

32.7 ± 17.1

FEF75, L/s

0.66 ± 0.39

0.42 ± 0.23*†

0.26 ± 0.14

FEF75% of predicted, %

70.9 ± 36.4

47.5 ± 21.4*†

30.2 ± 15.2

After bronchodilator use

   

MMEF, L/s

2.32 ± 0.85

1.51 ± 0.60*†

0.86 ± 0.41

MMEF% of predicted, %

93.3 ± 29.4

63.7 ± 23.7*†

34.9 ± 15.0

FEF50, L/s

3.13 ± 1.03

2.07 ± 0.72*†

1.19 ± 0.62

FEF50% of predicted, %

95.1 ± 27.1

65.5 ± 20.3*†

36.3 ± 17.3

FEF75, L/s

0.80 ± 0.43

0.52 ± 0.32*†

0.28 ± 0.14

FEF75% of predicted, %

85.6 ± 41.8

59.4 ± 33.9*†

32.8 ± 15.1

Impulse oscillometry§

   

R5¶, kPa/L/s

0.31 ± 0.09

0.36 ± 0.11*†

0.37 ± 0.13

R20¶, kPa/L/s

0.27 ± 0.07

0.29 ± 0.07*†

0.28 ± 0.07

R5-R20¶, kPa/L/s‡

0.04 (0.02 to 0.06)

0.06 (0.03 to 0.10)*†

0.07 (0.03 to 0.14)

AX, kPa/L‡

0.24 (0.15 to 0.40)

0.44 (0.27 to 0.73)*†

0.56 (0.23 to 1.51)

X5, kPa/L/s

-0.09 ± 0.04

-0.12 ± 0.04*†

-0.15 ± 0.10

Fres, Hz

12.39 ± 3.45

15.24 ± 4.31*†

17.81 ± 6.82

Radiographic measurements

   

LAA− 950, %‡

0.31 (0.11 to 0.78)

0.25 (0.09 to 0.66)*†

2.00 (0.67 to 5.92)

Perc 15, HU

-905 ± 20

-895 ± 30*†

-920 ± 24

LAA− 856, %‡

3.55 (1.11 to 8.42)

5.08 (1.87 to 11.6)†

25.87 (11.66 to 45.19)

HAA− 600 to −250, %‡

3.55 (3.19 to 4.06)

3.80 (3.42 to 4.66)*†

3.56 (3.16 to 4.09)

MLDE/I

0.82 ± 0.06

0.86 ± 0.06*†

0.91 ± 0.06

TLCCT, L

4.78 ± 1.05

4.15 ± 0.98*†

5.45 ± 1.13

TLCCT % of predicted, %

87.7 ± 22.0

76.7 ± 22.2*†

117.7 ± 35.4

RVCT, L‡

2.17 (1.82 to 2.59)

2.15 (1.81 to 2.52)†

3.29 (2.68 to 4.06)

RVCT % of predicted, %‡

103.1 (85.2 to 123.4)

101.4 (83.0 to 120.7)†

160.4 (123.9 to 201.1)

RV/TLCCT‡

0.46 (0.40 to 0.52)

0.52 (0.46 to 0.63)*†

0.61 (0.51 to 0.74)

  1. Data are mean ± standard deviation or median (interquartile range)
  2. Abbreviations: PRISm, preserved ratio impaired spirometry; COPD: chronic obstructive pulmonary disease; MMEF, maximal mid-expiratory flow; FEF50, forced expiratory flow 50%; FEF75, forced expiratory flow 75%; R5, Resistances at 5 Hz; R20, Resistances at 20 Hz; R5-R20: Resistances at 5 and 20 Hz; Ax, Reactance area; X5, Reactance at 5 Hz; Fres, Resonant frequency in Hz; LAA− 950, low-attenuation area of the lung with attenuation values below − 950 Hounsfield units; Perc 15, 15th percentile; HU, Hounsfield Unit; LAA− 856, low-attenuation area of the lung with attenuation values below − 856 Hounsfield units; HAA− 600 to −250, high-attenuation area of the lung with attenuation values of between − 600 Hounsfield units and − 250 Hounsfield units. MLDE/I, ratio of the mean lung density of expiration to inspiration; TLCCT, CT-measured total lung capacity; RVCT, CT-measured residual volume
  3. * P < 0.05 compared with healthy control using analysis of covariance adjusting for multiple comparisons using Bonferroni correction method
  4. † P < 0.05 compared with COPD using analysis of covariance adjusting for multiple comparisons using Bonferroni correction method
  5. Outcomes were adjusted for age, sex, body mass index, smoking status, and smoking index
  6. ‡ Use the natural log (ln) of the variables that were not normally distribution
  7. § Numbers of subjects with impulse oscillometry available: PRISm = 115, Healthy control = 589, Spirometry-defined COPD = 643.
  8. ¶ R5, R20, and R5-R20 were used as indicators of total airway resistance, proximal airway resistance, and peripheral airway resistance respectively